Targeted Gene Disruption Demonstrates That P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Required for P-Selectin–Mediated but Not E-Selectin–Mediated Neutrophil Rolling and Migration

Overview of attention for article published in The Journal of Experimental Medicine, December 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs: 1 blog

patent: 16 patents

Readers on

mendeley: 79 Mendeley

So far, Altmetric has seen 16 patents that reference this research output.

Anti-PSGL-1 antibodies and uses thereof

Grant US-11897964-B2

United States of America

13 Feb 2024

Methods of treating with anti-PSGL-1 antibodies

Grant US-10030075-B2

United States of America

24 Jul 2018

ANTI-P-SELECTIN ANTIBODIES AND METHODS OF THEIR USE AND IDENTIFICATION

Application EP-3222635-A1

European Patent Office

27 Sep 2017

Methods of treating GVHD and transplant rejection with anti-PSGL-1 antibodies

Grant US-9631019-B2

United States of America

25 Apr 2017

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 12 additional patents.